Investigation Overview
December 2, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Prosensa Holding NV (NASDAQ:RNA), was announced concerning whether the takeover of Prosensa Holding NV. by BioMarin Pharmaceutical Inc for $17.75 per share is unfair to NASDAQ:RNA stockholders. The investigation by a law firm concerns whether certain officers and directo...
You must register (for free) or login to view the entire investigation.